Benjamin Young named program manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Benjamin A. Young was named program manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, where he will work with researchers to coordinate the institute’s basic, clinical, and population sciences research programs.

Young’s primary responsibilities will include ensuring that clinical trials are conducted efficiently, acting as a liaison between basic and clinical researchers, and maintaining institute policies.

Before taking on this new role, Young was regulatory affairs lead at Fox Chase’s Office of Clinical Research. Prior to coming to Fox Chase, Young worked at the American Association for Cancer Research.

Table of Contents

YOU MAY BE INTERESTED IN

The long-awaited results from the RASolute 302 trial—a phase III clinical trial evaluating daraxonrasib, a RAS inhibitor, for the treatment of patients with previously treated, metastatic pancreatic ductal adenocarcinoma—have been read out. 
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login